ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cancer

Let’s Discuss Part 2: More Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR  |  October 28, 2025

The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on cutaneous manifestations of rheumatic diseases, gout, macrophage activation syndrome and vasculitis.

Filed under:ACR ConvergenceAmerican College of RheumatologyGout and Crystalline ArthritisMeeting ReportsOther Rheumatic ConditionsSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025GoutLupusmacrophage activation syndromeMethotrexatesystemic lupus erythematosus (SLE)Vasculitis

FDA Approves 2 More Denosumab Biosimilars

Michele B. Kaufman, PharmD, BCGP  |  October 27, 2025

The FDA as approved the biosimilar treatments denosumab-nxxp (Bildyos) and denosumab-nxxp (Bilprevda) for all indications of denosumab, their reference product, including osteoporosis in postmenopausal women.

Filed under:Biologics/DMARDsDrug Updates Tagged with:Biosimilarsdenosumabdenosumab-nxxpFDA approvalOsteoporosisU.S. Food and Drug Administration (FDA)

The 2025 ACR Awards of Distinction

Patrice Fusillo  |  October 25, 2025

The ACR honors excellence in rheumatology. Meet the 2025 Awards of Distinction recipients, ACR Masters & Distinguished Fellows recognized at ACR Convergence 2025.

Filed under:ACR ConvergenceAwardsCareerMeeting Reports Tagged with:ACR Convergence 2025ACR MastersDistinguished Clinical Investigatordistinguished fellowHenry Kunkel Young Investigator AwardhonorsPresidential Gold Medal

Insights into Mechanisms of Anti-Inflammatory Response to Exercise

Bryn Nelson, PhD  |  October 8, 2025

A recent Proceedings of the National Academy of Sciences study found that high-intensity aerobic exercise may reduce the release of cell-free DNA & tamp down inflammation over time.

Filed under:ConditionsGuidanceOther Rheumatic ConditionsResearch Rheum Tagged with:Cytokinesdendritic cellsDNAetosisExerciseImmune Systemmacrophagesneutrophils

What Rheumatologists Should Know About B Cell Tolerance & Autoimmunity

Katie Robinson  |  October 8, 2025

A recent Arthritis & Rheumatology review article explores the immune system’s mechanism for creating B cells that respond to diverse pathogens while preserving immune tolerance & highlights key insights for rheumatologists.

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:Alport syndromeanti-GBM diseaseautoantibodiesautoreactive B cellsB cell toleranceB cellsGlomerulonephritiskidney diseaseneoantigensT-cells

Rheumatologists Applaud Inclusion of Key Medications in Medicare Price Talks

From the College  |  October 5, 2025

In a powerful op-ed published by Fierce Healthcare, rheumatologists Amanda Myers, MD, and Rebecca Shepherd, MD, MBA—both volunteer advocates with the ACR—highlighted the critical role of the Centers for Medicare & Medicaid Services (CMS) in improving access to life-changing medications for patients with autoimmune and rheumatic diseases. Many patients with chronic conditions, such as rheumatoid…

Filed under:Legislation & Advocacy

Case Reports: Mimics of Polyarteritis Nodosa

Shane Murray, BMBS, RhMSUS, Zhe Ran Duan, MD, PhD, & Daniel DeMizio, MD  |  September 8, 2025

When polyarteritis nodosa isn’t PAN: Two cases of mimics, segmental arterial mediolysis (SAM) & vascular Ehlers-Danlos syndrome (vEDS), are explored.

Filed under:ConditionsVasculitis Tagged with:AAV FocusRheumaneurysmscase reportdifferential diagnosisEhlers-Danlosmimicspolyarteritis nodosasegmental arterial mediolysisvasculopathy

How to Diagnose Sjögren’s Disease

Samantha C. Shapiro, MD  |  August 26, 2025

Improve your Sjögren’s disease diagnosis. Experts discuss objective testing, seronegative cases, ILD screening & management strategies.

Filed under:ConditionsGuidancePractice SupportSjögren’s Disease Tagged with:biopsyDry eyeDry MouthDysautonomiaFibromyalgiaInterstitial Lung DiseaselymphomasiccaSjögren’s Disease supplementUltrasound

10 Ways to Manage Dry Mouth

Samantha C. Shapiro, MD  |  August 26, 2025

This article discusses 10 expert tips for mitigating dry mouth, a common symptom of Sjögren’s disease & other rheumatic conditions.

Filed under:ACR ConvergenceConditionsResearch RheumSjögren’s Disease Tagged with:Alternative MedicineAyurvedaDry Mouthoral healthpatient educationPractice Tipsquality of lifesalivary glandsSjögren’s Disease supplement

Small Fiber Neuropathy: What the Rheumatologist Needs to Know

Michael Cammarata, MD  |  August 26, 2025

An expert on peripheral neuropathy shares his practical approach to the diagnosis & management of small fiber neuropathy

Filed under:AnalgesicsConditionsDrug UpdatesPain SyndromesSjögren’s Disease Tagged with:antidepressantsbiopsyFibromyalgianeuropathyPainPain ManagementPeripheral NeuropathypregabalinSarcoidosisSjögren’s Disease supplementsmall fiber neuropathy

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 85
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences